| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |